The Identification and Cost of Acute Chronic Obstructive Pulmonary Disease Exacerbations in a United States Population Healthcare Claims Database

References

• World Health Organization. The top 10 causes of death . 2018. Available from: http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease . 2019. Available from: www.goldcopd.org
   Google Scholar
• Srivastava K , Thakur D , Sharma S , et al. Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease. Pharmacoeconomics. 2015;33(5):467–488. DOI:10.1007/s40273-015-0252-4
   PubMed Web of Science ®Google Scholar
• American Thoracic Society . What is an exacerbation? Am J Respir Crit Care Med. 2014;189:P11–P12.
   PubMed Web of Science ®Google Scholar
• Marks A . Managing acute exacerbations of COPD. US Pharmacist. 2009;34(7):HS-11–HS-15.
   Google Scholar
• Hawkins PE , Alam J , McDonnell TJ , et al. Defining exacerbations in chronic obstructive pulmonary disease. Expert Rev Respir Med. 2015;9(3):277–286. DOI:10.1586/17476348.2015.1046438
   PubMed Web of Science ®Google Scholar
• Montes de Oca M , Laucho-Contreras ME . Is it time to change the definition of acute exacerbation of chronic obstructive pulmonary disease? What do we need to add? Med Sci (Basel). 2018;6(2):50. DOI:10.3390/medsci6020050
   Google Scholar
• Oba Y , Keeney E , Ghatehorde N , et al. Dual combination therapy versus long‐acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta‐analysis. Cochrane Systematic Review. Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012620.pub2/full
   Google Scholar
• Anzueto A . Impact of exacerbations on COPD. Eur Respir Rev. 2010;19(116):113–118. DOI:10.1183/09059180.00002610
   PubMedGoogle Scholar
• Jones PW , Lamarca R , Chuecos F , et al. Characterisation and impact of reported and unreported exacerbations: results from ATTAIN. Eur Respir J. 2014;44(5):1156–1165. DOI:10.1183/09031936.00038814
   PubMed Web of Science ®Google Scholar
• Frei A , Siebeling L , Wolters C , et al. The inaccuracy of patient recall for COPD exacerbation rate estimation and its implications: Results from central adjudication. Chest. 2016;150(4):860–868. DOI:10.1016/j.chest.2016.06.031
   PubMed Web of Science ®Google Scholar
• Khwaja HA , Syed H , Cranston DW . Coding errors: a comparative analysis of hospital and prospectively collected departmental data. BJU Int. 2002;89(3):178–180. DOI:10.1046/j.1464-4096.2001.01428.x
   PubMed Web of Science ®Google Scholar
• Toy EL , Gallagher KF , Stanley EL , et al. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD. 2010;7(3):214–228. DOI:10.3109/15412555.2010.481697
   PubMedGoogle Scholar
• Shah T , Press VG , Huisingh-Scheetz M , et al . COPD readmissions: addressing COPD in the era of value-based Health Care. Chest. 2016;150(4):916–926. DOI:10.1016/j.chest.2016.05.002
   PubMed Web of Science ®Google Scholar
• US Department of Labor, Bureau of Labor Statistics . Consumer Price Index. Medical care in U.S. city average, all urban consumers, not seasonally adjusted. Series ID: CUUR0000SAM. Available from: http://data.bls.gov/cgi-bin/surveymost?cu
   Google Scholar
• Celli BR , MacNee W , Agusti, AATS , et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–946. DOI:10.1183/09031936.04.00014304
   PubMed Web of Science ®Google Scholar
• Stein BD , Bautista A , Schumock GT , et al. The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest. 2012;141(1):87–93. DOI:10.1378/chest.11-0024
   PubMed Web of Science ®Google Scholar
• Wu EQ , Birnbaum HG , Cifaldi M , et al. Development of a COPD severity score. Curr Med Res Opin. 2006;22(9):1679–1687. DOI:10.1185/030079906X115621
   PubMed Web of Science ®Google Scholar
• Erdal M , Johannessen A , Eagan TM , et al. Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients. Int J Chron Obstruct Pulmon Dis. 2016;11:2099–2108. DOI:10.2147/COPD.S108720
   PubMed Web of Science ®Google Scholar
• Hurst JR , Vestbo J , Anzueto A , et al. Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2010;363(12):1128–1138. DOI:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Han MLK , Quibrera PM , Carretta EE , et al. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(8):619–626. DOI:10.1016/S2213-2600(17)30207-2
   PubMed Web of Science ®Google Scholar
• Worth H , Buhl R , Criée CP , et al. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study. Respir Med. 2017;131:77–84. DOI:10.1016/j.rmed.2017.08.008
   PubMed Web of Science ®Google Scholar
• Pasquale MK , Sun SX , Song F , et al. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2012;7:757–764. DOI:10.2147/COPD.S36997
   PubMed Web of Science ®Google Scholar
• Elixhauser A , Au DH , Podulka J . Healthcare cost and utilization project (HCUP) statistical briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006, Feb–2011 Sep.
   Google Scholar
• Perera PN , Armstrong EP , Sherrill DL , et al. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012;9(2):131–141. DOI:10.3109/15412555.2011.650239
   PubMedGoogle Scholar
• Jinjuvadia C , Jinjuvadia R , Mandapakala C , et al. Trends in outcomes, financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD) in the United States from 2002 to 2010. COPD. 2017;14(1):72–79. DOI:10.1080/15412555.2016.1199669
   PubMedGoogle Scholar
• Global Initiative for Asthma and Global Initiative for Chronic Obstructive Lung Disease. Asthma, COPD and Asthma-COPD overlap syndrome . 2015. Available from: https://goldcopd.org/asthma-copd-asthma-copd-overlap-syndrome/
   Google Scholar
• Wurst KE , St Laurent S , Hinds D , et al. Disease burden of patients with asthma/COPD overlap in a US claims database: impact of ICD-9 coding-based definitions. COPD. 2017;14(2):200–209. DOI:10.1080/15412555.2016.1257598
   PubMedGoogle Scholar
• Ferver K , Burton B , Jesilow P . The use of claims data in healthcare research. Open Public Health J. 2009;2(1):11–24. DOI:10.2174/1874944500902010011
   Google Scholar
• Montes de Oca M , Tálamo C , Halbert RJ , et al. Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) study. Chest. 2009;136(1):71–78. DOI:10.1378/chest.08-2081
   PubMed Web of Science ®Google Scholar